Literature DB >> 12634494

Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes.

Kunikazu Tanji1, Fumiaki Mori, Tadaatsu Imaizumi, Hidemi Yoshida, Kei Satoh, Koichi Wakabayashi.   

Abstract

Tau phosphorylation is associated with neurite outgrowth and morphogenesis in neurons. Since inflammatory stimuli induce marked morphological changes in astrocytes, we examined the effect of interleukin 1alpha (IL-1alpha), an inflammatory cytokine, on the expression and phosphorylation of tau protein in cultured human astrocytes. Western blot analysis showed a rapid and transient increase (3-30 min) of tau phosphorylation at the AT8 epitope. The cells began to extend processes from 24 h after IL-1alpha stimulation. It is known that tau phosphorylation at the AT8 epitope reduces its ability to bind to, and stabilize, microtubules. The early tau phosphorylation induced by IL-1alpha might create a plastic environment for morphological changes in astrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634494     DOI: 10.1097/00001756-200303030-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.

Authors:  Travis Dunckley; Thomas G Beach; Keri E Ramsey; Andrew Grover; Diego Mastroeni; Douglas G Walker; Bonnie J LaFleur; Keith D Coon; Kevin M Brown; Richard Caselli; Walter Kukull; Roger Higdon; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2005-10-19       Impact factor: 4.673

Review 2.  Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.

Authors:  Matthew J Sharman; Giuseppe Verdile; Shanmugam Kirubakaran; Cristina Parenti; Ahilya Singh; Georgina Watt; Tim Karl; Dennis Chang; Chun Guang Li; Gerald Münch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

3.  Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.

Authors:  Masashi Kitazawa; David Cheng; Michelle R Tsukamoto; Maya A Koike; Paul D Wes; Vitaly Vasilevko; David H Cribbs; Frank M LaFerla
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

4.  Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.

Authors:  Guo-Biao Xu; Pei-Pei Guan; Pu Wang
Journal:  Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.590

5.  Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's Therapy.

Authors:  Anna Chiarini; Ubaldo Armato; Emanuela Gardenal; Li Gui; Ilaria Dal Prà
Journal:  Front Neurosci       Date:  2017-04-20       Impact factor: 4.677

Review 6.  Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease.

Authors:  Jong Kil Lee; Nam-Jung Kim
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

7.  Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.

Authors:  Jacob S Friedberg; Nurgul Aytan; Jonathan D Cherry; Weiming Xia; Oliver J Standring; Victor E Alvarez; Raymond Nicks; Sarah Svirsky; Gaoyuan Meng; Gyungah Jun; Hoon Ryu; Rhoda Au; Thor D Stein
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

8.  The excitotoxin quinolinic acid induces tau phosphorylation in human neurons.

Authors:  Abdur Rahman; Kaka Ting; Karen M Cullen; Nady Braidy; Bruce J Brew; Gilles J Guillemin
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

9.  COX-2 metabolic products, the prostaglandin I2 and F, mediate the effects of TNF-α and Zn2+ in stimulating the phosphorylation of Tau.

Authors:  Yue Wang; Pei-Pei Guan; Xin Yu; Yan-Su Guo; Ying-Jie Zhang; Zhan-You Wang; Pu Wang
Journal:  Oncotarget       Date:  2017-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.